Univest
Univest
  • Markets

Ipca Laboratories (IPCALAB) Share Price Falls 2.30% to Rs 1,823.80 on 17 November

  • September 3, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Ipca Laboratories Share Price
Ipca Laboratories (IPCALAB) share price fell to Rs 1,823.8 today, down 2.3% from the previous close. Market cap was Rs 47,828.32 crore.

The Ipca Laboratories Share Price fell 2.30% on 17 November 2026, with the stock last traded at Rs 1,823.80 against a previous close of Rs 1,866.75, according to Univest data as of 2:52:59 PM IST. The Large Cap pharmaceuticals company carries a market capitalisation of Rs 47,828.32 crore, which keeps the Ipca Laboratories Share Price Today in focus among Healthcare names.

According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The Ipca Laboratories stock news flow on Univest does not tie today’s share price fall to any announcement, so this report sticks to verified price action, fundamental analysis, sector analysis and peer comparison. Investors tracking Ipca Laboratories Stock News can watch how the Ipca Laboratories Share Price Update develops through the rest of the session.

Table of Contents

Toggle
  • Ipca Laboratories (IPCALAB) Share Price Today: Price Action Analysis
  • Ipca Laboratories (IPCALAB) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Ipca Laboratories
  • About Ipca Laboratories
  • Track Ipca Laboratories Share Price on Univest
  • Frequently Asked Questions
    • What is the Ipca Laboratories Share Price today?
    • Why is the Ipca Laboratories stock falling today?
    • What is the market capitalisation of Ipca Laboratories?
    • What are the day high and day low of Ipca Laboratories?
    • What is the P/E ratio of Ipca Laboratories?
    • What are the ROE and ROCE of Ipca Laboratories?
    • What are the EPS and book value of Ipca Laboratories?
    • What is the dividend yield of Ipca Laboratories?
    • How does Ipca Laboratories compare with its peers?

Ipca Laboratories (IPCALAB) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,823.8
Previous Close Rs 1,866.75
Today's Move -Rs 42.95 (-2.3%)
Open Rs 1,871.3
High Rs 1,875.7
Low Rs 1,823.8
Market Capitalisation Rs 47,828.32 crore
Market Cap Category Large Cap

The Ipca Laboratories Share Price Today shows a fall of Rs 42.95, or 2.30%, from the previous close of Rs 1,866.75 to Rs 1,823.80 as of 2:52:59 PM IST. This is a Large Cap stock with a market capitalisation of Rs 47,828.32 crore, and the Ipca Laboratories Share Price Fall was recorded at 2:52:48 PM IST on 17 November 2026.

The session opened at Rs 1,871.30, which was above the previous close, and the stock touched a high of Rs 1,875.70 before sliding. The day low of Rs 1,823.80 is the same level at which the Ipca Laboratories Share Price last traded, so the stock was at its lowest point of the session at the time of writing. The intraday range of Rs 1,823.80 to Rs 1,875.70 shows the stock moved between those two levels, and the gap between the open and the latest price is Rs 47.50.

This is the latest session only, so the Ipca Laboratories Stock Falling Today reading is a single-day move rather than a multi-session streak. The Ipca Laboratories Stock Performance in this session therefore needs fundamental context, which the next section provides.

Ipca Laboratories (IPCALAB) Fundamental Analysis

Metric Value
Market Capitalisation Rs 47,828.32 crore
P/E Ratio 33.77x
P/B Ratio 5.46x
ROE 15.88%
ROCE 19.41%
EPS Rs 55.28
Book Value Per Share Rs 342.06
Dividend Yield 0.32%

Ipca Laboratories (IPCALAB) fundamental metrics show P/E 33.77x, P/B 5.46x, ROE 15.88%, ROCE 19.41%. These figures provide context only and are not a buy or sell signal.

Ipca Laboratories has a market capitalisation of Rs 47,828.32 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 33.77x, P/B at 5.46x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.88% and ROCE of 19.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 55.28, book value per share of Rs 342.06, dividend yield of 0.32%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.46x, median ROE of 11.33%, median ROCE of 13.1%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 33.77x
Benchmark Median P/E 30.46x
Benchmark Average P/E 52.1x
Benchmark P/E Range 2.82x to 1,227.27x
Company P/B Ratio 5.46x
Benchmark Median P/B 2.92x
Benchmark Average P/B 3.28x
Company ROE 15.88%
Benchmark Median ROE 11.33%
Benchmark Average ROE 5.24%
Company ROCE 19.41%
Benchmark Median ROCE 13.1%
Benchmark Average ROCE 12.07%
Company Market Capitalisation Rs 47,828.32 crore
Benchmark Median Market Cap Rs 760.34 crore
Benchmark Average Market Cap Rs 14,899.39 crore

Ipca Laboratories (IPCALAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Ipca Laboratories (IPCALAB) has a P/E ratio of 33.77x, which is above the benchmark median of 30.46x, a difference of +10.87%. On its own, the P/E gap is a valuation reference point, not a trading call.

Ipca Laboratories (IPCALAB) has a ROE of 15.88%, which is above the benchmark median of 11.33%, a difference of +40.16%. Ipca Laboratories (IPCALAB) has a ROCE of 19.41%, which is above the benchmark median of 13.1%, a difference of +48.17%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,51,290.91 40.85 5.02 14.85 19.11
Divi's Laboratories DIVISLAB 3,05,014.11 87.71 16.39 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,77,333.2 83.99 9.71 26.76 19.27
Laurus Labs LAURUSLABS 1,30,755.56 89.4 19.77 18.31 18.2
Zydus Lifesciences ZYDUSLIFE 1,18,802.71 28.37 4.26 19.69 21.39

Ipca Laboratories (IPCALAB) has a P/E ratio of 33.77x compared with the displayed peer median of 83.99x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 15.88% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 19.41% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ipca Laboratories (IPCALAB) has a market capitalisation of Rs 47,828.32 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Ipca Laboratories

  • The Ipca Laboratories Share Price fell 2.30% to Rs 1,823.80 from a previous close of Rs 1,866.75.
  • The stock touched its day low of Rs 1,823.80 after a high of Rs 1,875.70 and an open of Rs 1,871.30.
  • ROE of 15.88% and ROCE of 19.41% are both above the industry benchmark median.
  • The P/E ratio of 33.77 is above the benchmark median of 30.46 but below the benchmark average of 52.10.
  • Market capitalisation of Rs 47,828.32 crore places the Large Cap company well above the industry median.

About Ipca Laboratories

Ipca Laboratories is a listed Indian company in the Pharmaceuticals & Drugs industry, part of the wider Healthcare sector. The company is classified as Large Cap by market capitalisation, at Rs 47,828.32 crore. Within its industry benchmark of 200 companies, it ranks well above the median size of Rs 760.34 crore, while its P/E of 33.77, P/B of 5.46, ROE of 15.88% and ROCE of 19.41% describe the valuation and return profile used throughout this Company Overview.

Track Ipca Laboratories Share Price on Univest

Use Ipca Laboratories (IPCALAB) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can track the live Ipca Laboratories Share Price, fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and wider market insights on Univest. Univest brings the Ipca Laboratories Share Price Live, valuation benchmarks and Healthcare sector peers together in one place, so a move like today’s share price fall can be read alongside the company’s fundamentals. The Ipca Laboratories Share Price Update on Univest refreshes through the trading day.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the Ipca Laboratories Share Price today?

Ans. The Ipca Laboratories Share Price last traded at Rs 1,823.80 as of 2:52:59 PM IST on 17 November 2026, down Rs 42.95 or 2.30% from the previous close of Rs 1,866.75, according to Univest data.

Why is the Ipca Laboratories stock falling today?

Ans. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The Ipca Laboratories stock fell 2.30% from Rs 1,866.75 to Rs 1,823.80, and Univest reports no news item behind the move.

What is the market capitalisation of Ipca Laboratories?

Ans. Ipca Laboratories has a market capitalisation of Rs 47,828.32 crore and is classified as a Large Cap company. Market capitalisation describes company size, not business quality, and it sits well above the industry median of Rs 760.34 crore.

What are the day high and day low of Ipca Laboratories?

Ans. The Ipca Laboratories Share Price touched a high of Rs 1,875.70 and a low of Rs 1,823.80 on 17 November 2026, after opening at Rs 1,871.30. The latest traded price equals the day low.

What is the P/E ratio of Ipca Laboratories?

Ans. Ipca Laboratories has a P/E ratio of 33.77 and a P/B ratio of 5.46. The industry benchmark P/E median is 30.46 and the average is 52.10, so the company P/E sits between the two.

What are the ROE and ROCE of Ipca Laboratories?

Ans. Ipca Laboratories reports an ROE of 15.88% and an ROCE of 19.41%. Both sit above the industry benchmark medians of 11.33% and 13.10%, which gives the Ipca Laboratories Fundamental Analysis a solid return profile.

What are the EPS and book value of Ipca Laboratories?

Ans. Ipca Laboratories has an EPS of Rs 55.28 and a book value of Rs 342.06 per share. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.

What is the dividend yield of Ipca Laboratories?

Ans. The dividend yield of Ipca Laboratories is 0.32%, measured against the current share price of Rs 1,823.80. Dividend yield reflects historical payout relative to price and does not guarantee any future dividend from the company.

How does Ipca Laboratories compare with its peers?

Ans. Ipca Laboratories has a P/E of 33.77, below Sun Pharmaceutical at 40.85 and above Zydus Lifesciences at 28.37. Its ROCE of 19.41% is above Torrent Pharmaceuticals at 19.27%, but its market capitalisation is smaller than all five peers.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply